文献速递消化道肿瘤与早癌消化内镜

年轻结直肠肿瘤患者监测结肠镜中异时性肿瘤的风险

Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia.
PubMed 文献 · Gastrointest Endosc · 2017-06-12

该多中心回顾性队列研究比较了20-49岁与50-54岁人群按基线风险分层的异时性肿瘤发生率。在基线高风险腺瘤组,3年异时性进展期肿瘤风险年轻组为10.7%、年长组为8.9%(P > .1);低风险腺瘤组5年风险分别为4.9%和5.1%(P > .1);无肿瘤组5年风险分别为4.1%和5.6%(P > .1)。作者建议无强家族史的年轻高风险腺瘤患者监测间隔为3年、低风险腺瘤为5年。

要点

  • 基线高风险腺瘤年轻组3年异时性进展期肿瘤风险10.7%,年长组8.9%(P > .1)。
  • 基线低风险腺瘤年轻组5年风险4.9%,年长组5.1%(P > .1)。
  • 作者建议无强家族史年轻高风险腺瘤监测间隔3年、低风险腺瘤5年。

核心结论

  • 考虑到年轻与年长个体异时性进展期肿瘤风险相似,作者建议无强家族史的年轻高风险腺瘤患者监测间隔为3年、低风险腺瘤为5年。

研究设计与样本

  • 多中心回顾性队列研究,比较年轻(20-49岁)与年长(50-54岁)队列按基线风险分层的异时性肿瘤发生率。
  • 纳入2006年6月至2010年5月间首次结肠镜检查且至2015年6月至少接受1次监测结肠镜检查的受试者。
  • 共10477例接受基线结肠镜检查,排除755例后9722例符合条件,其中43%接受了监测结肠镜检查。

主要发现

  • 基线高风险腺瘤组(n=840)3年异时性进展期肿瘤风险:年轻筛查结肠镜患者10.7% vs 年长患者8.9%(P > .1)。
  • 基线低风险腺瘤组(n=1869)5年异时性进展期肿瘤风险:年轻筛查结肠镜患者4.9% vs 年长患者5.1%(P > .1)。
  • 基线无肿瘤组(n=7013)5年异时性进展期肿瘤风险:年轻筛查结肠镜患者4.1% vs 年长患者5.6%(P > .1)。

关键数值与推荐

  • 基线高风险腺瘤组:年轻患者3年异时性进展期肿瘤风险10.7%,年长患者8.9%(P > .1)。
  • 基线低风险腺瘤组:年轻患者5年异时性进展期肿瘤风险4.9%,年长患者5.1%(P > .1)。
  • 基线无肿瘤组:年轻患者5年异时性进展期肿瘤风险4.1%,年长患者5.6%(P > .1)。

临床怎么用

  • 作者建议无强家族史的年轻高风险腺瘤患者监测结肠镜间隔为3年。
  • 作者建议无强家族史的年轻低风险腺瘤患者监测结肠镜间隔为5年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Few prior reports exist that address the appropriate colonoscopy surveillance interval for individuals <50 years old. We compared the risk of metachronous neoplasia between younger (20-49 years) and older (50-54 years) cohorts. METHODS: This multicenter retrospective cohort study compared the incidence of metachronous neoplasia in younger and older cohorts according to baseline risk stratification. Subjects were eligible if they underwent their first colonoscopy between June 2006 and May 2010 and had at least 1 or more surveillance colonoscopy up to June 2015. RESULTS: Among a total of 10,477 subjects who underwent baseline colonoscopy, 9722 were eligible after excluding 755 subjects. Of those 9722 subjects, 43% underwent surveillance colonoscopy. In the baseline high-risk adenoma group (n = 840), the 3-year risk of metachronous advanced neoplasia was 10.7% in the younger patients on screening colonoscopy and 8.9% in the older patients (P > .1). In the baseline low-risk adenoma group (n = 1869), the 5-year risk of metachronous advanced neoplasia was 4.9% in the younger patients on screening colonoscopy and 5.1% in the older patients (P > .1). Similarly, in the baseline no neoplasia group (n = 7013), the 5-year risk of metachronous advanced neoplasia was 4.1% in the younger patients on screening colonoscopy and 5.6% in the older patients (P > .1). CONCLUSIONS: Considering the similar risk of metachronous advanced neoplasia in younger and older individuals, we suggest a 3-year surveillance interval for high-risk adenoma and a 5-year surveillance interval for low-risk adenoma in young individuals without a strong family history.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Kim HG, Cho YS, Cha JM, et al. Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia. Gastrointest Endosc. 2017. PMID: 28619245. doi:10.1016/j.gie.2017.05.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。